Parental Interventions for Young Children with Autism
Trial Summary
What is the purpose of this trial?
The overarching goal of the proposed study is to: (a) determine how best to sequence two parent-mediated interventions: a social communication intervention (Project ImPACT, Improving Parents as Communication Teachers) and a disruptive behavior intervention (Parent Training for Disruptive Behavior) and (b) examine moderators and mediators of intervention outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Parental Interventions for Young Children with Autism?
Research shows that parent training programs, like the ones used in the study, can significantly reduce disruptive behaviors in children with autism. For example, a study found that a structured parent training program led to a 54% decrease in disruptive behavior, and another study showed that Parent-Child Interaction Therapy (PCIT) improved parent-child relationships and reduced disruptive behaviors in children with autism.12345
Is parent training for children with autism safe?
How is the treatment 'Parental Interventions for Young Children with Autism' different from other treatments for autism?
This treatment is unique because it involves training parents to manage disruptive behaviors and improve social communication in children with autism, using a structured program that can be delivered in a group format. This approach helps address the shortage of specialized services and empowers parents to implement strategies in daily routines, potentially increasing adherence and effectiveness.12356
Research Team
Eligibility Criteria
This trial is for young children aged 18 to 48 months who are on the autism spectrum, as indicated by specific research criteria. They should not have other diagnoses or disabilities, must have normal vision, and be exposed to English at least half of the time. A caregiver must be willing and able to learn intervention strategies and understand conversational English.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
First-stage Intervention
Participants receive either the Social Communication or Disruptive Behavior intervention for 12 weeks
Second-stage Intervention
Participants are re-randomized to continue, switch, or augment their intervention based on fidelity of implementation
Follow-up
Participants are monitored for outcomes such as social communication, disruptive behavior, and family life participation
Treatment Details
Interventions
- Disruptive Behavior (Behavioural Intervention)
- Social Communication (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
University of Texas at Austin
Collaborator
Dr. Elly Barry
University of Texas at Austin
Chief Medical Officer
MD from Harvard Medical School
Dr. Brian Windsor
University of Texas at Austin
Chief Executive Officer since 2023
PhD in Molecular Biology from the University of Texas at Austin